The double-blind, placebo-controlled, ascending, single and multiple, oral dose study is designed to provide preliminary information on the safety, tolerability and pharmacokinetics of PSN602 in healthy lean and
Mr Skolnik was previously a managing director in the health care group at Piper Jaffray & Company. Prior to joining Piper Jaffray, where he was a founding member
The new European patent expands the available Zenvia dose ranges under prior patent protection and encompasses the company’s current clinical development programs in pseudobulbar affect and diabetic peripheral
Perrigo’s Cetirizine syrup is comparable to McNeil Consumer Healthcare’s Zyrtec syrup, 1mg/mL, indicated for the relief of symptoms associated with seasonal allergic rhinitis. Joseph Papa, chairman and CEO
The two globally conducted, multi-center, Phase III, randomized, double-blind comparative studies were designed to evaluate the efficacy and safety of ceftaroline compared to vancomycin plus aztreonam. In both
After the merger is completed, clickNsettle will be renamed Cardo Medical and will be headquartered in Los Angeles. The merger is expected to close in the third quarter
Following an antibiotic washout period, 36 patients will be enrolled to receive daily inhaled liposomal ciprofloxacin for a period of 28 consecutive days. The primary efficacy endpoint will
The three large-scale, randomized, double-blind, placebo-controlled, multi-center, add-on Phase III trials in partial epilepsy included an aggregate of 1,049 patients 18 years of age or older from 23
Rajesh Shrotriya, chairman, president, and CEO of Spectrum, said: “The establishment of Spectrum Pharma Canada is another important milestone as we build a global pharmaceutical organization. “The Canadian
No differences in heart rate, heart rhythm or blood pressure were observed between MB07811 and placebo-treated patients. Mild increases in liver enzymes were observed at the higher doses
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.